US Bancorp
MREO

US Bancorp’s Mereo BioPharma MREO Stock Holding History

US Bancorp’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4 Hold
13
– – ﹤0.01% 4161
2025
Q4 		$5 Hold
13
– – ﹤0.01% 4029
2025
Q3 		$27 Hold
13
– – ﹤0.01% 3983
2025
Q2 		$35 Hold
13
– – ﹤0.01% 4132
2025
Q1 		$29 Hold
13
– – ﹤0.01% 4160
2024
Q4 		$46 Hold
13
– – ﹤0.01% 4123
2024
Q3 		$53 Hold
13
– – ﹤0.01% 4045
2024
Q2 		$47 Sell
13
-400
-97% -$1.3K ﹤0.01% 3938
2024
Q1 		$1.36K Buy
413
+400
+3,077% +$1.35K ﹤0.01% 3782
2023
Q4 		$30 Hold
13
– – ﹤0.01% 3938
2023
Q3 		$17 Hold
13
– – ﹤0.01% 3964
2023
Q2 		$17 Hold
13
– – ﹤0.01% 3970
2023
Q1 		$9 Hold
13
– – ﹤0.01% 4071
2022
Q4 		$10 Hold
13
– – ﹤0.01% 4125
2022
Q3 		$0 Hold
13
– – ﹤0.01% 4159
2022
Q2 		$0 Hold
13
– – ﹤0.01% 4159
2022
Q1 		$0 Hold
13
– – ﹤0.01% 4149
2021
Q4 		$0 Buy
+13
New +$26 ﹤0.01% 4183

Other funds holding MREO

RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
6CM
683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $712M AUM
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return